C1S and chronic inflammatory demyelinating polyradiculoneuropathy: Data generated with these models can also provide support for repurposing existing drugs as indicated by a previous study for testing C1s inhibition in a clinical trial of the autoimmune demyelinating neuropathy, CIDP (NCT04658472), and suggests great potential for microphysiological systems use for translational research leading to IND generation [52].